IRINOTECAN HCL (irinotecan HCl)

100 mg/5 mL intravenous solution

• Dosage information is not available

300 mg/15 mL intravenous solution

• Dosage information is not available

40 mg/2 mL intravenous solution

• Dosage information is not available

500 mg/25 mL intravenous solution

• Dosage information is not available

100 mg/5 mL intravenous solution

• Dosage information is not available

300 mg/15 mL intravenous solution

• Dosage information is not available

40 mg/2 mL intravenous solution

• Dosage information is not available

500 mg/25 mL intravenous solution

• Dosage information is not available

irinotecan 100 mg/5 mL intravenous solution

• Dosage information is not available

irinotecan 300 mg/15 mL intravenous solution

• Dosage information is not available

irinotecan 40 mg/2 mL intravenous solution

• Dosage information is not available

irinotecan 500 mg/25 mL intravenous solution

• Dosage information is not available

100 mg/5 mL intravenous solution

• Dosage information is not available

300 mg/15 mL intravenous solution

• Dosage information is not available

40 mg/2 mL intravenous solution

• Dosage information is not available

Metastatic colorectal cancer

• Infuse 125 mg/m2 over 90 minute(s) by intravenous route on days 1, 8,15 and 22 of a 6 week cycle

• Infuse 180 mg/m2 over 90 minute(s) by intravenous route on days 1, 15And 29 of a 6 week cycle

• Infuse 125 mg/m2 over 90 minute(s) by intravenous route on days 1, 8,15 and 22 of a weekly regimen then rest 2 weeks

• Infuse 350 mg/m2 over 90 minute(s) by intravenous route every 3 weeks

• Infuse 100 mg/m2 over 90 minute(s) by intravenous route on days 1, 8,15 and 22 of a 6 week cycle

• Infuse 150 mg/m2 over 90 minute(s) by intravenous route on days 1, 15And 29 of a 6 week cycle

• Infuse 100 mg/m2 over 90 minute(s) by intravenous route on days 1, 8,15 and 22 of a weekly regimen then rest 2 weeks

• Infuse 300 mg/m2 over 90 minute(s) by intravenous route every 3 weeks

• Infuse 75 mg/m2 over 90 minute(s) by intravenous route on days 1, 8, 15 and 22 of a 6 week cycle

• Infuse 120 mg/m2 over 90 minute(s) by intravenous route on days 1, 15And 29 of a 6 week cycle

• Infuse 75 mg/m2 over 90 minute(s) by intravenous route on days 1, 8, 15 and 22 of a weekly regimen then rest 2 weeks

• Infuse 250 mg/m2 over 90 minute(s) by intravenous route every 3 weeks

• Infuse 200 mg/m2 over 90 minute(s) by intravenous route every 3 weeks

• Infuse 50 mg/m2 over 90 minute(s) by intravenous route on days 1, 8, 15 and 22 of a weekly regimen then rest 2 weeks

• Infuse 150 mg/m2 over 90 minute(s) by intravenous route on days 1, 8,15 and 22 of a weekly regimen then rest 2 weeks

• Infuse 48 mg/m2 over 90 minute(s) by intravenous route on days 1, 8, 15 and 22 of a 6 week cycle

• Infuse 60 mg/m2 over 90 minute(s) by intravenous route on days 1, 8, 15 and 22 of a 6 week cycle

• Infuse 96 mg/m2 over 90 minute(s) by intravenous route on days 1, 15 and 29 of a 6 week cycle

• Infuse 76.8 mg/m2 over 90 minute(s) by intravenous route on days 1, 15 and 29 of a 6 week cycle